Chinese Journal of Pharmacovigilance ›› 2025, Vol. 22 ›› Issue (3): 346-348.
DOI: 10.19803/j.1672-8629.20240473

• Orginal Article • Previous Articles     Next Articles

One Case of Neurotoxicity Caused by Fluorouracil Injection in a Patient with Metastatic Colorectal Cancer

MIN Qiong1,2, LI Peng2,3, DAI Xiaoyan1, FAN Chunling1, YOU Haisheng2,*   

  1. 1Department of Pharmacy, Gansu Provincial Cancer Hospital, Lanzhou Gansu 730000, China;
    2Department of Pharmacy, the First Affiliated Hospital of Xi’an Jiaotong University, Xi’an Shaanxi 710000, China;
    3Department of Pharmacy, Yangling District Rougu Hospital, Xianyang Shaanxi 712000, China
  • Received:2024-08-12 Online:2025-03-15 Published:2025-03-17

Abstract: Objective To analyze one case of neurotoxicity caused by fluorouracil. Methods One case of acute neurotoxicity was investigated. The cause of neurotoxicity was identified by analyzing the diagnosis and treatment of the patient while the suspected drug was evaluated via causality assessment of adverse event. Results Neurotoxicity in this patient was considered to have been caused by the rising dose of fluorouracil. After subsequent treatment at a reduced dose of fluorouracil, the patient did not experience any more adverse reactions. Conclusion Toxicity can be increased when fluorouracil is used in intraperitoneal perfusion chemotherapy and intravenous chemotherapy at the same time. In order to decrease the risk of toxicity, clinicians ought to prescribe a lower dosage or choose a different drug.

Key words: Fluorouracil, Injection, Intraperitoneal Perfusion Chemotherapy, Neurotoxicity, Metastatic Colorectal Cancer, Adverse Drug Reactions

CLC Number: